pmcc logo smlHere are the staff publications for March 2018, compiled 5th April 2018. 



Here are the staff publications for March 2018.

Compiled by the Health Sciences Library (RMH, RWH, PMCC and Victorian Mental Health) 5th April 2018.


  1. Adam A, Hellig JC, Perera M, Bolton D, Lawrentschuk N. 'Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS). World Journal of Urology 2018;36:565-73.
  2. Aref-Adib M, Vlachodimitropoulou E, Khasriya R, Lamb BW, Selo-Ojeme D. UK O&G trainees' attitudes to caesarean delivery for maternal request. Journal of Obstetrics and Gynaecology 2018;38:367-71.
  3. Arora S, Chun B, Ahlawat RK, Abaza R, Adshead J, Porter JR, Challacombe B, Dasgupta P, Gandaglia G, Moon DA, Yuvaraja TB, Capitanio U, Larcher A, Porpiglia F, Mottrie A, Bhandari M, Rogers C. Conversion of Robot-assisted Partial Nephrectomy to Radical Nephrectomy: A Prospective Multi-institutional Study. Urology 2018;113:85-90.
  4. Bailey DL, Hofman MS, Forwood NJ, O'Keefe GJ, Scott AM, van Wyngaardt WM, Howe B, Kovacev O, Francis RJ, Artnet, and the Pro PTI. Accuracy of Dose Calibrators for (68)Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment. Journal of Nuclear Medicine 2018;59:636-8.
  5. Ballinger ML, Ferris NJ, Moodie K, Mitchell G, Shanley S, James PA, Thomas DM. Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging. JAMA Oncology 2017;3:1735-6.
  6. Behrenbruch C, Lippey J, Spillane J, Henderson M, Heriot A. Colocolonic intussusception from metastatic melanoma. ANZ Journal of Surgery 2018;88:E214-e5.
  7. Bird TG, Ngan SY, Chu J, Kroon R, Lynch AC, Heriot AG. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent. Int J Colorectal Dis 2018;33:393-401.
  8. Carey KT, Wickramasinghe VO. Regulatory Potential of the RNA Processing Machinery: Implications for Human Disease. Trends in Genetics 2018;34:279-90.
  9. Caria S, Magtoto CM, Samiei T, Portela M, Lim KYB, How JY, Stewart BZ, Humbert PO, Richardson HE, Kvansakul M. Drosophila melanogaster Guk-holder interacts with the Scribbled PDZ1 domain and regulates epithelial development with Scribbled and Discs Large. Journal of Biological Chemistry 2018;293:4519-31.
  10. Carpinteri S, Sampurno S, Malaterre J, Millen R, Dean M, Kong J, Chittleborough T, Heriot A, Lynch AC, Ramsay RG. Experimental study of delivery of humidified-warm carbon dioxide during open abdominal surgery. British Journal of Surgery 2018;105:597-605.
  11. Chittleborough TJ, Kong JC, Guerra GR, Ramsay R, Heriot AG. Colonoscopic surveillance: quality, guidelines and effectiveness. ANZ Journal of Surgery 2018;88:32-8.
  12. Christidis D, Clarebrough E, Ly V, Perera M, Woo H, Lawrentschuk N, Bolton D. Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy. World Journal of Urology 2018;36:575-84.
  13. Clemons NJ, Liu DS, Duong CP, Phillips WA. Inhibiting system xC(-) and glutathione biosynthesis - a potential Achilles' heel in mutant-p53 cancers. Mol Cell Oncol 2017;4:e1344757.
  14. Colebatch AJ, Witkowski T, Waring PM, McArthur GA, Wong SQ, Dobrovic A. Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations. Clinical Chemistry 2018;64:745-7.
  15. Corfield J. (68)Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review. World Journal of Urology 2018;36:519-27.
  16. Corfield JM, Abouassaly R, Lawrentschuk N. Health information quality on the internet for bladder cancer and urinary diversion: a multi-lingual analysis. Minerva Urologica e Nefrologica 2018;70:137-43.
  17. Curry E, Zeller C, Masrour N, Patten DK, Gallon J, Wilhelm-Benartzi CS, Ghaem-Maghami S, Bowtell DD, Brown R. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis. Cancer Research 2018;78:1383-91.
  18. Dagan E, Kleid S. Obviating the need for sternotomy: Safety and effectiveness of microdebrider use for retrosternal goiter. HEAD & NECK 2018;40:837-41.
  19. Davenport AJ, Cross RS, Watson KA, Liao Y, Shi W, Prince HM, Beavis PA, Trapani JA, Kershaw MH, Ritchie DS, Darcy PK, Neeson PJ. Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity. Proceedings of the National Academy of Sciences U S A 2018;115:E2068-e76.
  1. Dreno B, Ascierto PA, Atkinson V, Liszkay G, Maio M, Mandala M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Bartley K, Karagiannis T, Chang I, Rooney I, Koralek DO, Larkin J, McArthur GA, Ribas A. Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF(V600) mutation-positive melanoma. British Journal of Cancer 2018;118:777-84.
  2. Dwight T, Flynn A, Amarasinghe K, Benn DE, Lupat R, Li J, Cameron DL, Hogg A, Balachander S, Candiloro ILM, Wong SQ, Robinson BG, Papenfuss AT, Gill AJ, Dobrovic A, Hicks RJ, Clifton-Bligh RJ, Tothill RW. TERT structural rearrangements in metastatic pheochromocytomas. Endocrine Related Cancer 2018;25:1-9.
  3. El-Galaly TC, Cheah CY, Bendtsen MD, Nowakowski GS, Kansara R, Savage KJ, Connors JM, Sehn LH, Goldschmidt N, Shaulov A, Farooq U, Link BK, Ferreri AJM, Calimeri T, Cecchetti C, Dann EJ, Thompson CA, Inbar T, Maurer MJ, Gade IL, Juul MB, Hansen JW, Holmberg S, Larsen TS, Cordua S, Mikhaeel NG, Hutchings M, Seymour JF, Clausen MR, Smith D, Opat S, Gilbertson M, Thanarajasingam G, Villa D. Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. European Journal of Cancer 2018;93:57-68.
  4. Fujihara KM, Clemons NJ. Bridging the molecular divide: alcohol-induced downregulation of PAX9 and tumour development. Journal of Pathology 2018;244:386-8.
  5. Gascoyne RD, Nadel B, Pasqualucci L, Fitzgibbon J, Payton JE, Melnick A, Weigert O, Tarte K, Gribben JG, Friedberg JW, Seymour JF, Cavalli F, Zucca E. Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015. Hematological Oncology 2017;35:397-407.
  6. George J, Walter V, Peifer M. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nature Communications 2018;9:1048.
  7. Gherardin NA, Loh L, Admojo L. Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma. Scientific Reports 2018;8:4159.
  8. Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf A, Ryan A, Chudecka-Glaz A, Magliocco AM, Hartmann A, Jung AY, Gao B, Hernandez BY, Fridley BL, McCauley BM, Kennedy CJ, Wang C, Karpinskyj C, de Sousa CB, Tiezzi DG, Wachter DL, Herpel E, Taran FA, Modugno F, Nelson G, Lubinski J, Menkiszak J, Alsop J, Lester J, Garcia-Donas J, Nation J, Hung J, Palacios J, Rothstein JH, Kelley JL, de Andrade JM, Robles-Diaz L, Intermaggio MP, Widschwendter M, Beckmann MW, Ruebner M, Jimenez-Linan M, Singh N, Oszurek O, Harnett PR, Rambau PF, Sinn P, Wagner P, Ghatage P, Sharma R, Edwards RP, Ness RB, Orsulic S, Brucker SY, Johnatty SE, Longacre TA, Ursula E, McGuire V, Sieh W, Natanzon Y, Li Z, Whittemore AS, Anna A, Staebler A, Karlan BY, Gilks B, Bowtell DD, Hogdall E, Candido dos Reis FJ, Steed H, Campbell IG, Gronwald J, Benitez J, Koziak JM, Chang-Claude J, Moysich KB, Kelemen LE, Cook LS, Goodman MT, Garcia MJ, Fasching PA, Kommoss S, Deen S, Kjaer SK, Menon U, Brenton JD, Pharoah PDP, Chenevix-Trench G, Huntsman DG, Winham SJ, Kobel M, Ramus SJ. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. JAMA Oncology 2017;3:e173290.
  9. Gyorki DE, Choong PFM, Slavin J, Henderson MA. Importance of preoperative diagnosis for management of patients with suspected retroperitoneal sarcoma. ANZ Journal of Surgery 2018;88:274-7.
  10. Haeusler GM, Thursky KA, Slavin MA, Mechinaud F, Babl FE, Bryant P, De Abreu Lourenco R, Phillips R. External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules. Pediatric Infectious Disease Journal 2018;37:329-35.
  11. Haskali MB, Roselt PD, Hicks RJ, Hutton CA. Automated preparation of 2-[(18) F]fluoropropionate labeled peptides using a flexible, multi-stage synthesis platform (iPHASE Flexlab). Journal of Labelled Compounds & Radiopharmaceuticals 2018;61:61-7.
  12. Hellig JC, Perera M, Bolton D, Lawrentschuk N, Carpinteri S, Sampurno S, Malaterre J, Millen R, Dean M, Kong J, Chittleborough T, Heriot A, Lynch AC, Ramsay RG. Experimental study of delivery of humidified-warm carbon dioxide during open abdominal surgery. World Journal of Urology 2018;105:597-605.
  13. Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nature Reviews Clinical Oncology 2018;15:205-18.
  14. Hofman MS, Eu P, Jackson P, Hong E, Binns D, Iravani A, Murphy D, Mitchell C, Siva S, Hicks RJ, Young JD, Blower PJ, Mullen GE. Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of (68)Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer. Journal of Nuclear Medicine 2018;59:625-31.
  15. Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J. Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. Supportive Care in Cancer 2017;25:3171-9.
  16. Jiao M, Hall AE, Nolte L, Piper A, Lisy K, Jefford M. A rapid review of needs assessment tools for post-treatment cancer survivors. European Journal of Cancer Care (Engl) 2018;27:e12764.
  1. Johnson CE, Bennett KS, Newton J, McTigue J, Taylor S, Musiello T, Lau PKH. A pilot study to assess the validity of the DASS-21 subscales in an outpatient oncology population. Psychooncology 2018;27:695-9.
  2. Lawrentschuk N. Evolution of technologies in urology: full steam ahead? World Journal of Urology 2018;36:517-8.
  3. Lindqvist LM, Tandoc K, Topisirovic I, Furic L. Cross-talk between protein synthesis, energy metabolism and autophagy in cancer. Curr Opin Genet Dev 2018;48:104-11.
  4. Lonski P, Ramachandran P, Franich R, Kron T. Surface dose measurements in and out of field: Implications for breast radiotherapy with megavoltage photon beams. Z Med Phys 2017;27:318-23.
  5. Lopez JA, Noori T, Minson A, Li Jovanoska L, Thia K, Hildebrand MS, Akhlaghi H, Darcy PK, Kershaw MH, Brown NJ, Grigg A, Trapani JA, Voskoboinik I. Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing. Frontiers in Immunology 2018;9:529.
  6. Manning TG, O'Brien JS, Christidis D, Perera M, Coles-Black J, Chuen J, Bolton DM, Lawrentschuk N. Three dimensional models in uro-oncology: a future built with additive fabrication. World Journal of Urology 2018;36:557-63.
  7. Martin CA, Cullinane C, Kirby L, Abuhammad S, Lelliott EJ, Waldeck K, Young RJ, Brajanovski N, Cameron DP, Walker R, Sanij E, Poortinga G, Hannan RD, Pearson RB, Hicks RJ, McArthur GA, Sheppard KE. Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance. International Journal of Cancer 2018;142:2139-52.
  8. McCarthy MC, McNeil R, Drew S, Orme L, Sawyer SM. Information needs of adolescent and young adult cancer patients and their parent-carers. Supportive Care in Cancer 2018;26:1655-64.
  9. McMullen M, Lau PKH, Taylor S, McTigue J, Cook A, Bamblett M, Hasani A, Johnson CE. Factors associated with psychological distress amongst outpatient chemotherapy patients: An analysis of depression, anxiety and stress using the DASS-21. Applied Nursing Research 2018;40:45-50.
  10. Mikropoulos C, Hutten Selkirk CG, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, Jensen T, Osther PJ, van Asperen CJ, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, Hart R, Glover W, Lam J, Taylor L, Salinas M, Feliubadalo L, Oldenburg R, Cremers R, Verhaegh G, van Zelst-Stams WA, Oosterwijk JC, Cook J, Rosario DJ, Buys SS, Conner T, Domchek S, Powers J, Ausems M, Teixeira MR, Maia S, Izatt L, Schmutzler R, Rhiem K, Foulkes WD, Boshari T, Davidson R, Ruijs M, Helderman-van den Enden A, Andrews L, Walker L, Snape K, Henderson A, Jobson I, Lindeman GJ, Liljegren A, Harris M, Adank MA, Kirk J, Taylor A, Susman R, Chen-Shtoyerman R, Pachter N, Spigelman A, Side L, Zgajnar J, Mora J, Brewer C, Gadea N, Brady AF, Gallagher D, van Os T, Donaldson A, Stefansdottir V, Barwell J, James PA, Murphy D, Friedman E, Nicolai N, Greenhalgh L, Obeid E, Murthy V, Copakova L, McGrath J, Teo SH, Strom S, Kast K, Leongamornlert DA, Chamberlain A, Pope J, Newlin AC, Aaronson N, Ardern-Jones A, Bangma C, Castro E, Dearnaley D, Eyfjord J, Falconer A, Foster CS, Gronberg H, Hamdy FC, Johannsson O, Khoo V, Lubinski J, Grindedal EM, McKinley J, Shackleton K, Mitra AV, Moynihan C, Rennert G, Suri M, Tricker K, Moss S, Kote-Jarai Z, Vickers A, Lilja H, Helfand BT, Eeles RA. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. British Journal of Cancer 2018;118:e17.
  11. Mileshkin LR, Freimund AE. Improvement of Outcomes for Women With HIV Infection and Cervical Cancer. Journal of Clinical Oncology 2016;34:3719-21.
  12. Mui M, Akhurst T, Warrier SK, Lynch AC, Heriot AG. Detection of incidental colorectal pathology on positron emission tomography/computed tomography. ANZ Journal of Surgery 2018;88:E122-E6.
  13. Musiienko AM, Alzahrani S, Simpson JAD, Warrier S, Lynch AC, Heriot AG. Preoperative chemoradiation for an ascending colon tumour: novel approach to achieve a complete resection. ANZ Journal of Surgery 2018;88:E342-e4.
  14. Nesic K, Wakefield M. Targeting DNA repair: the genome as a potential biomarker. Journal of Pathology 2018;244:586-97.
  15. O'Brien JS, Manning T, Perera M, Prince HM, Lawrentschuk N. Blueprint unknown: a case for multidisciplinary management of advanced penile mycosis fungoides. Canadian Journal of Urology 2017;24:9139-44.
  16. Ow D, Papa N, Perera M, Liodakis P, Sengupta S, Clarke S, Bolton DM, Lawrentschuk N. Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital. ANZ Journal of Surgery 2018;88:95-9.
  17. Perera M, Bolton D, Lawrentschuk N, Curry E, Zeller C, Masrour N, Patten DK, Gallon J, Wilhelm-Benartzi CS, Ghaem-Maghami S, Bowtell DD, Brown R. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis. World Journal of Urology 2018;78:1383-91.
  18. Photiou L, van der Weyden C, McCormack C, Miles Prince H. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sezary Syndrome. Current Oncology Reports 2018;20:32.
  1. Ranasinghe W, Wang LL, Persad R, Bolton D, Lawrentschuk N, Sengupta S. Survival outcomes in elderly men undergoing radical prostatectomy in Australia. ANZ Journal of Surgery 2018;88:E189-E93.
  2. Rawstron AC, Kreuzer KA, Soosapilla A, Spacek M, Stehlikova O, Gambell P, McIver-Brown N, Villamor N, Psarra K, Arroz M, Milani R, de la Serna J, Cedena MT, Jaksic O, Nomdedeu J, Moreno C, Rigolin GM, Cuneo A, Johansen P, Johnsen HE, Rosenquist R, Niemann CU, Kern W, Westerman D, Trneny M, Mulligan S, Doubek M, Pospisilova S, Hillmen P, Oscier D, Hallek M, Ghia P, Montserrat E. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry Part B, Clinical Cytometry 2018;94:121-8.
  3. Roelli MA, Ruffieux-Daidie D, Stooss A, ElMokh O, Phillips WA, Dettmer MS, Charles RP. PIK3CA(H1047R)-induced paradoxical ERK activation results in resistance to BRAF(V600E) specific inhibitors in BRAF(V600E) PIK3CA(H1047R) double mutant thyroid tumors. Oncotarget 2017;8:103207-22.
  4. Sathianathen NJ, Lamb AD, Lawrentschuk NL, Goad JR, Peters J, Costello AJ, Murphy DG, Moon DA. Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years. ANZ Journal of Surgery 2018;88:E200-E3.
  5. Savitski MM, Zinn N, Faelth-Savitski M, Poeckel D, Gade S, Becher I, Muelbaier M, Wagner AJ, Strohmer K, Werner T, Melchert S, Petretich M, Rutkowska A, Vappiani J, Franken H, Steidel M, Sweetman GM, Gilan O, Lam EYN, Dawson MA, Prinjha RK, Grandi P, Bergamini G, Bantscheff M. Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis. Cell 2018;173:260-74.e25.
  6. Seymour JF, Kipps TJ, Eichhorst B, Hillmen P, D'Rozario J, Assouline S, Owen C, Gerecitano J, Robak T, De la Serna J, Jaeger U, Cartron G, Montillo M, Humerickhouse R, Punnoose EA, Li Y, Boyer M, Humphrey K, Mobasher M, Kater AP. Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia. New England Journal of Medicine 2018;378:1107-20.
  7. Skaczkowski G, White V, Thompson K, Bibby H, Coory M, Pinkerton R, Orme LM, Conyers R. Do Australian adolescents' and young adults' experiences of cancer care influence their quality of life? Psychooncology 2018;27:990-7.
  8. Steigedal TS, Toraskar J, Redvers RP, Valla M, Magnussen SN, Bofin AM, Opdahl S, Lundgren S, Eckhardt BL, Lamar JM, Doherty J, Hynes RO, Anderson RL, Svineng G. Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs. Neoplasia 2018;20:387-400.
  9. Stewart CM, Kothari PD, Mouliere F. The value of cell-free DNA for molecular pathology. Journal of Pathology 2018;244:616-27.
  10. Surtees TC, Teh BW, Slavin MA, Worth LJ. Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience. Vaccine 2018;36:1804-7.
  11. Tam CS, Anderson MA, Pott C, Agarwal R, Handunnetti S, Hicks RJ, Burbury K, Turner G, Di Iulio J, Bressel M, Westerman D, Lade S, Dreyling M, Dawson SJ, Dawson MA, Seymour JF, Roberts AW. Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma. New England Journal of Medicine 2018;378:1211-23.
  12. Tan JL, Frydenberg M, Grummet J, Hanegbi U, Snow R, Mann S, Begashaw K, Moon D. Comparison of perioperative, renal and oncologic outcomes in robotic-assisted versus open partial nephrectomy. ANZ Journal of Surgery 2018;88:E194-E9.
  13. Tan WS, Tan MY, Lamb BW, Sridhar A, Mohammed A, Baker H, Nathan S, Briggs T, Tan M, Kelly JD. Intracorporeal robot-assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains. BJU International 2018;121:632-9.
  14. Tonkin-Hill GQ, Trianty L, Noviyanti R, Nguyen HHT, Sebayang BF, Lampah DA, Marfurt J, Cobbold SA, Rambhatla JS, McConville MJ, Rogerson SJ, Brown GV, Day KP, Price RN, Anstey NM, Papenfuss AT, Duffy MF. The Plasmodium falciparum transcriptome in severe malaria reveals altered expression of genes involved in important processes including surface antigen-encoding var genes. PLoS Biology 2018;16:e2004328.
  15. Udovicich C, Soh B, Law S, Hoe V, Lanfranco D, Perera K, Duong C, Chan S. Predictive factors for publication of abstracts at the Royal Australasian College of Surgeons Annual Scientific Congress. ANZ Journal of Surgery 2018;88:39-44.
  16. Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D, Hauschild A, Menzies AM, Arance A, Ascierto PA, Giacomo AD, de Rosa F, Larkin J, Park JJ, Goldinger SM, Sullivan RJ, Xu W, Livingstone E, Weichenthal M, Rai R, Gaba L, Long GV, Lorigan P. Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116-124]. European Journal of Cancer 2018;93:158.
  17. Van Gelder R, Wong S, Le A, Podreka A, Briggs A, Haddad C, Hardcastle N. Experience with an abdominal compression band for radiotherapy of upper abdominal tumours. Journal of Medical Radiation Sciences 2018;65:48-54.
  1. Warrier SK, Kong JC, Guerra GR, Chittleborough TJ, Naik A, Ramsay RG, Lynch AC, Heriot AG. Risk Factors Associated With Circumferential Resection Margin Positivity in Rectal Cancer: A Binational Registry Study. Diseases of the Colon & Rectum 2018;61:433-40.
  2. Yong MK, Lewin SR, Manuel O. Immune Monitoring for CMV in Transplantation. Current Infectious Disease Reports 2018;20:4.